A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push
Clinical trial NCT02503293 · COMPLETED
Trial details
- NCT number
- NCT02503293
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-29
- Primary completion
- 2017-12-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.